Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Alere Inc (NYSE: ALR) acted responsibly on behalf of investors’ profitability in the planned $5.8 billion sale to Abbott Laboratories (NYSE: ABT).

On February 1, 2016, Alere Inc (NYSE: ALR) and Abbott Laboratories (NYSE: ABT) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Abbott Laboratories will offer Alere Inc shareholders $56 per share in cash for all outstanding shares.

Based in Waltham, Massachusetts, and founded in 1981 Alere Inc provides point-of-care diagnostics and services for infectious disease, cardiometabolic disease, and toxicology.

The investigation is looking to uncover whether Alere Inc was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $60.00 per share.

If you purchased Alere Inc (NYSE: ALR) prior to February 1, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185